Vitamin D recommendations should reduce Rickets (but not much else)

European Food Safety Authority March 2016 posted draft for comment:

Scientific Opinion on Dietary Reference Values for vitamin D

📄 Download the PDF from Vitamin D Life

EFSA, proposes:

20 ng level and 600 IU intake (with ZERO for age 0 to 6 months)

20 nanograms is enough to deal with Rickets

    but 40+ nanograms is needed for other BONE and BODY health

image

Is 50 ng of vitamin D too high, just right, or not enough has the following summary chart

image

  • Virtually all studes define 30 ng as sufficient

  • Many experts say 40 ng is good

  • Some experts say 50 ng is much better for disease prevention

  • Some experts say 50 ng is too much

    • But some experts feel 50 ng is not enough to TREAT diseases

EFSA summarizes some current recomendations

ADULT

image

CHILD

image

PREGNANT/LACTATING

image

SACN UK Scientific Advisory Committee on Nutrition
D-A-CH Germany Deutschland- Austria- Confoederatio Helvetica
NCM Nordic Countries Nordic Council of Ministers
NL Netherlands
IOM U.S. Institute of Medicine of the National Academy of Sciences
WHO Globe World Health Organization
Afssa France Agence française de sécurité sanitaire des aliments
SCF Europe Scientific Committee for Food
DH UK UK Department of Health

Virtually all recommendations fail to notice


Falls in Vitamin D Life


Europe in Vitamin D Life


Death due to low vitamin D in Vitamin D Life


Pregnancy and Vitamin D in Vitamin D Life

Healthy pregnancies need lots of vitamin D has the following summary

{include}


Bones problems in Vitamin D Life

See also Vitamin D Life


Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) derived Dietary Reference Values (DRVs) for vitamin D. The Panel considers that serum 25(OH)D concentration, which reflects the amount of vitamin D attained from both cutaneous synthesis and dietary sources, can be used as biomarker of vitamin D status in adult and children populations. The Panel notes that the evidence on the relationship between serum 25(OH)D concentration and musculoskeletal health outcomes in adults, infants and children, and adverse pregnancy-related health outcomes, is widely variable. The Panel considers that Average Requirements and Population Reference Intakes for vitamin D cannot be derived, and therefore defines Adequate Intakes (AIs), for all population groups. Taking into account the overall evidence and uncertainties, the Panel considers that a serum 25(OH)D concentration of 50 nmol/L is a suitable target value for all population groups, in view of setting the AIs. * For adults, an AI for vitamin D is set at 15 ug/day, based on a meta-regression analysis and considering that, at this intake, most of the population will achieve a serum 25(OH)D concentration near or above the target of 50 nmol/L. * For children aged 1-17 years, an AI for vitamin D is set at 15 ug/day , based on the meta-regression analysis. * For infants aged 7-11 months, an AI for vitamin D is set at 10 ug/day , based on trials in infants. * For pregnant and lactating women, the Panel sets the same AI as for non-pregnant non-lactating women, i.e. 15 ug/day . The Panel underlines that the meta-regression was done on data collected under conditions of minimal cutaneous vitamin D synthesis. In the presence of cutaneous vitamin D synthesis, the requirement for dietary vitamin D is lower or may even be zero.